Annual report pursuant to Section 13 and 15(d)

Basis of Presentation

v3.8.0.1
Basis of Presentation
12 Months Ended
Dec. 31, 2017
Basis of Presentation  
Basis of Presentation

1.Basis of Presentation

 

The accompanying consolidated financial statements include the accounts of AxoGen, Inc. (the “Company” or “AxoGen”) and its wholly owned subsidiaries, AxoGen Corporation (“AC”) and AxoGen Europe GmbH, established in the fourth quarter of 2016, as of December 31, 2017 and December 31, 2016 and for the three years ended December 31, 2017. The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. All significant intercompany accounts and transactions have been eliminated in consolidation.